Hepatitis C and tumors: immune checkpoint inhibitors safe and effective?

被引:0
|
作者
Simon, Annika
机构
来源
ZEITSCHRIFT FUR GASTROENTEROLOGIE | 2024年 / 62卷 / 02期
关键词
D O I
10.1055/a-2181-4090
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Wirkstoffe aus der Gruppe der Immun-Checkpoint-Inhibitoren (ICI) haben in den letzten Jahren die Krebstherapie revolutioniert und konnten auch fur Patient*innen mit soliden Tumorerkrankungen und komorbider chronischer Hepatitis-C-Infektion eine neue Therapieoption darstellen. Yibirin et al. wollten daher mehr uber den virologischen Einfluss der ICI und ihre Sicherheit erfahren, und haben eine prospektive Beobachtungsstudie zum Thema durchgefuhrt.
引用
收藏
页码:156 / 158
页数:2
相关论文
共 50 条
  • [41] Immune checkpoint inhibitors
    Kitano, S.
    ANNALS OF ONCOLOGY, 2024, 35 : S1305 - S1305
  • [42] Immune Checkpoint Inhibitors
    West, Howard
    JAMA ONCOLOGY, 2015, 1 (01) : 115 - 115
  • [43] Tumors bearing defective transcription elongation are immune hot but resistant to immune checkpoint inhibitors
    Modur, Vishnu
    Guo, Fukun
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):
  • [44] Immune checkpoint inhibitors
    Kroemer, Guido
    Zitvogel, Laurence
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (03):
  • [45] Severe immune-related hepatitis induced by immune checkpoint inhibitors: Clinical features and
    Gauci, Marie-Lea
    Baroudjian, Barouyr
    Bederede, Ulysse
    Zeboulon, Charlotte
    Delyon, Julie
    Allayous, Clara
    Madelaine, Isabelle
    Eftekhari, Pirayeh
    Resche-Rigon, Matthieu
    Pote, Nicolas
    Paradis, Valerie
    Durand, Francois
    Lebbe, Celeste
    Roux, Olivier
    Bouattour, Mohamed
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)
  • [46] The study of immune checkpoint inhibitors in chronic hepatitis B virus infection
    Li, Siyu
    Li, Na
    Yang, Shanru
    Deng, Haiyan
    Li, Yanguo
    Wang, Yixuan
    Yang, Jiaqiang
    Lv, Jiaxin
    Dong, Lan
    Yu, Guansen
    Hou, Xin
    Wang, Geng
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2022, 109
  • [47] Combined Radioimmunotherapy with Immune Checkpoint Inhibitors for stereotactic Irradiation of Lung Tumors
    Kraus, K.
    Bauer, C.
    Borm, K.
    Combs, S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S142 - S143
  • [48] Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors
    Beibei Pei
    Xiaoyan Ma
    Na Wu
    Chen Wang
    Wenhui Yang
    ChineseJournalofCancerResearch, 2023, 35 (03) : 252 - 265
  • [49] How Can Immune Checkpoint Inhibitors Cause Hyperprogression in Solid Tumors?
    Denis, Morgane
    Duruisseaux, Michael
    Brevet, Marie
    Dumontet, Charles
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [50] Effect of microbiome group on immune checkpoint inhibitors in treatment of gastrointestinal tumors
    Pei, Beibei
    Ma, Xiaoyan
    Wu, Na
    Wang, Chen
    Yang, Wenhui
    CHINESE JOURNAL OF CANCER RESEARCH, 2023, 35 (03) : 252 - 265